Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

241 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Liver Matrix in Benign and Malignant Biliary Tract Disease.
Fabris L, Cadamuro M, Cagnin S, Strazzabosco M, Gores GJ. Fabris L, et al. Semin Liver Dis. 2020 Aug;40(3):282-297. doi: 10.1055/s-0040-1705109. Epub 2020 Mar 11. Semin Liver Dis. 2020. PMID: 32162285 Review.
Cholangiocarcinoma 2020: the next horizon in mechanisms and management.
Banales JM, Marin JJG, Lamarca A, Rodrigues PM, Khan SA, Roberts LR, Cardinale V, Carpino G, Andersen JB, Braconi C, Calvisi DF, Perugorria MJ, Fabris L, Boulter L, Macias RIR, Gaudio E, Alvaro D, Gradilone SA, Strazzabosco M, Marzioni M, Coulouarn C, Fouassier L, Raggi C, Invernizzi P, Mertens JC, Moncsek A, Rizvi S, Heimbach J, Koerkamp BG, Bruix J, Forner A, Bridgewater J, Valle JW, Gores GJ. Banales JM, et al. Among authors: fabris l. Nat Rev Gastroenterol Hepatol. 2020 Sep;17(9):557-588. doi: 10.1038/s41575-020-0310-z. Epub 2020 Jun 30. Nat Rev Gastroenterol Hepatol. 2020. PMID: 32606456 Free PMC article. Review.
Targeted therapies for extrahepatic cholangiocarcinoma: preclinical and clinical development and prospects for the clinic.
Cadamuro M, Lasagni A, Lamarca A, Fouassier L, Guido M, Sarcognato S, Gringeri E, Cillo U, Strazzabosco M, Marin JJ, Banales JM, Fabris L. Cadamuro M, et al. Among authors: fabris l. Expert Opin Investig Drugs. 2021 Apr;30(4):377-388. doi: 10.1080/13543784.2021.1880564. Epub 2021 Feb 23. Expert Opin Investig Drugs. 2021. PMID: 33622120 Free PMC article. Review.
The Neglected Role of Bile Duct Epithelial Cells in NASH.
Cadamuro M, Lasagni A, Sarcognato S, Guido M, Fabris R, Strazzabosco M, Strain AJ, Simioni P, Villa E, Fabris L. Cadamuro M, et al. Among authors: fabris r, fabris l. Semin Liver Dis. 2022 Feb;42(1):34-47. doi: 10.1055/s-0041-1739455. Epub 2021 Nov 18. Semin Liver Dis. 2022. PMID: 34794182
Cholangiocarcinoma landscape in Europe: Diagnostic, prognostic and therapeutic insights from the ENSCCA Registry.
Izquierdo-Sanchez L, Lamarca A, La Casta A, Buettner S, Utpatel K, Klümpen HJ, Adeva J, Vogel A, Lleo A, Fabris L, Ponz-Sarvise M, Brustia R, Cardinale V, Braconi C, Vidili G, Jamieson NB, Macias RI, Jonas JP, Marzioni M, Hołówko W, Folseraas T, Kupčinskas J, Sparchez Z, Krawczyk M, Krupa Ł, Scripcariu V, Grazi GL, Landa-Magdalena A, Ijzermans JN, Evert K, Erdmann JI, López-López F, Saborowski A, Scheiter A, Santos-Laso A, Carpino G, Andersen JB, Marin JJ, Alvaro D, Bujanda L, Forner A, Valle JW, Koerkamp BG, Banales JM. Izquierdo-Sanchez L, et al. Among authors: fabris l. J Hepatol. 2022 May;76(5):1109-1121. doi: 10.1016/j.jhep.2021.12.010. Epub 2022 Feb 12. J Hepatol. 2022. PMID: 35167909 Free article.
Targeting NAE1-mediated protein hyper-NEDDylation halts cholangiocarcinogenesis and impacts on tumor-stroma crosstalk in experimental models.
Olaizola P, Lee-Law PY, Fernandez-Barrena MG, Alvarez L, Cadamuro M, Azkargorta M, O'Rourke CJ, Caballero-Camino FJ, Olaizola I, Macias RIR, Marin JJG, Serrano-Maciá M, Martinez-Chantar ML, Avila MA, Aspichueta P, Calvisi DF, Evert M, Fabris L, Castro RE, Elortza F, Andersen JB, Bujanda L, Rodrigues PM, Perugorria MJ, Banales JM. Olaizola P, et al. Among authors: fabris l. J Hepatol. 2022 Jul;77(1):177-190. doi: 10.1016/j.jhep.2022.02.007. Epub 2022 Feb 23. J Hepatol. 2022. PMID: 35217064 Free article.
Criteria for preclinical models of cholangiocarcinoma: scientific and medical relevance.
Calvisi DF, Boulter L, Vaquero J, Saborowski A, Fabris L, Rodrigues PM, Coulouarn C, Castro RE, Segatto O, Raggi C, van der Laan LJW, Carpino G, Goeppert B, Roessler S, Kendall TJ, Evert M, Gonzalez-Sanchez E, Valle JW, Vogel A, Bridgewater J, Borad MJ, Gores GJ, Roberts LR, Marin JJG, Andersen JB, Alvaro D, Forner A, Banales JM, Cardinale V, Macias RIR, Vicent S, Chen X, Braconi C, Verstegen MMA, Fouassier L; CCA Model Consortium. Calvisi DF, et al. Among authors: fabris l. Nat Rev Gastroenterol Hepatol. 2023 Jul;20(7):462-480. doi: 10.1038/s41575-022-00739-y. Epub 2023 Feb 8. Nat Rev Gastroenterol Hepatol. 2023. PMID: 36755084 Free article. Review.
Epithelial-mesenchymal interactions in biliary diseases.
Fabris L, Strazzabosco M. Fabris L, et al. Semin Liver Dis. 2011 Feb;31(1):11-32. doi: 10.1055/s-0031-1272832. Epub 2011 Feb 22. Semin Liver Dis. 2011. PMID: 21344348 Free PMC article. Review.
Clinical outcome indicators in chronic hepatitis B and C: A primer for value-based medicine in hepatology.
Strazzabosco M, Cortesi PA, Conti S, Okolicsanyi S, Rota M, Ciaccio A, Cozzolino P, Fornari C, Gemma M, Scalone L, Cesana G, Fabris L, Colledan M, Fagiuoli S, Ideo G, Zavaglia C, Perricone G, Munari LM, Mantovani LG, Belli LS. Strazzabosco M, et al. Among authors: fabris l. Liver Int. 2020 Jan;40(1):60-73. doi: 10.1111/liv.14285. Epub 2019 Nov 12. Liver Int. 2020. PMID: 31654608 Free PMC article.
241 results